Clinica Baviera, a company specializing in ophthalmological care, appears to present a compelling undervalued investment opportunity when examining its financial fundamentals. Through a detailed analysis of its free cash flow, return on equity (ROE), and dividend distribution policy, we shed light on why this undervaluation exists and the long-term valuation prospects.